Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » No Coronavirus Transmission in Womb, Study Says
Clinical Breakthroughs

No Coronavirus Transmission in Womb, Study Says

By Will DossFeb 14, 2020
Share
Facebook Twitter Email
Wei Zhang, PhD, associate professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention and co-author of the study published in The Lancet.

As new cases of the novel coronavirus known as COVID-19 were reported in China and beyond, concerns about possible transmission of coronavirus from pregnant mothers to their unborn children also arose, after Chinese state media reported on an infected patient who gave birth to a baby who later tested positive for the virus.

A new study published in The Lancet, however, has found no evidence that COVID-19 is passed from women in their third trimester to their unborn fetus in the womb, a mechanism known as vertical transmission, based on examination of medical records and tissue samples from nine pregnant patients who were infected with the disease.

If proper isolation practices during and after birth are followed, women diagnosed with COVID-19 should be able to deliver healthy babies without the infection, said Wei Zhang, PhD, associate professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention and co-author of the study.  

Wei cautioned, however, that these results may not be generalizable to earlier-stage pregnancies.

“Many pregnant women are concerned right now, and these findings confirm there’s no scientific evidence for vertical transmission,” Zhang said. “But all of the women in this study were in the later stages of pregnancy: we don’t yet know about any potential transmission during earlier trimesters.”

Investigators at Wuhan University studied nine pregnant women who were diagnosed with COVID-19 during the third trimester of their pregnancies. The scientists analyzed samples of amniotic fluid and umbilical cord blood taken before birth, then tested the infants after they were delivered via caesarean section, finding no evidence of COVID-19 in any fluids.

A caesarean section and isolation — separating the infant from the mother — are crucial to ensuring the infant does not contract COVID-19 during or after birth, according to Zhang.

“The baby is at a high risk of infection after birth, so everything should proceed carefully; the baby should be removed from the infected mother immediately and be put under close monitoring,” Zhang said.

In addition, and while it’s a small sample, women in this study did not experience pregnancy complications similar to those often experienced in pregnant women with another, similar disease: severe acute respiratory syndrome coronavirus (SARS-CoV).

While both infectious diseases are coronaviruses first discovered in China, COVID-19 continues to show significant differences from SARS-CoV. Notably, COVID-19 appears to be much more infectious and, according to Zhang, the number of infected could be more than 100,000 people — meaning the number of pregnant women with the infection also could be much higher.

“That’s why it’s important to provide this clinical evidence,” Zhang said. “We found that with preparation and isolation, these women should be able to birth a healthy baby and that’s important for families all over the world.”

Before the COVID-19 outbreak, Zhang was working with investigators at Wuhan University to discover genetic biomarkers for early detection of ovarian cancer and diabetic complications. After the outbreak, the Wuhan team shifted their focus to COVID-19, and Zhang, working from Chicago, provided epidemiology and data interpretation on the study.

This study was supported by Hubei Science and Technology Plan grant 2017ACB640 and Wuhan University Medical Development Plan grant TFJC2018001.

COVID-19 Global Health Public Health Research
Share. Facebook Twitter Email

Related Posts

Coaxing Hair Growth in Aging Hair Follicle Stem Cells

Jun 9, 2023

New Therapeutic Target for Osteoarthritis Identified 

Jun 9, 2023

Largest Cell Map of Human Lung Reveals Insights Into Disease

Jun 8, 2023

Comments are closed.

Latest News

Coaxing Hair Growth in Aging Hair Follicle Stem Cells

Jun 9, 2023

New Therapeutic Target for Osteoarthritis Identified 

Jun 9, 2023

Largest Cell Map of Human Lung Reveals Insights Into Disease

Jun 8, 2023

McNally Honored with Walder Award

Jun 8, 2023

Biological Aging Increases Risk of Depression, Anxiety in Adults 

Jun 7, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
ANB05555
ANB08990
ANB09022
ANB09063
ANB09008
ANB08781
ANB08971
ANB09000
ANB08992
ANB09015
ANB09058
ANB09048

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.